The New Zealand Herald

F&P Healthcare leads NZX 50 to record

A2 Milk remains volatile, takes a fall after previous gains

-

New Zealand shares rose, pushing the S&P/NZX 50 Index to a record, as Fisher & Paykel Healthcare extended its gains and investors picked up stocks carrying a dividend payment including Ryman Healthcare, Mainfreigh­t and Arvida Group.

The NZX 50 rose 56.41 points, or 0.6 per cent, to 8,813.45. Within the index, 24 stocks rose, 19 fell and seven were unchanged. Turnover was $165 million. F&P Healthcare rose 3.5 per cent to $14.40, bringing its gains the past week to about 10 per cent. On May 28 the company posted a record profit of $190.2m and said it would beat that in the current year even while planning increased capital ex- penditure. The company sheds its final dividend of 12.5 cents a share on June 21.

“There was some scepticism about (Healthcare’s) growth prospects and expenditur­e but investors have got their heads around the fact that it is investing for growth,” said Peter McIntyre, an investment adviser at Craigs Investment Partners. “It’s an easily understood, long-term story. A quality company.”

Ryman, which pays a 10.9 cent final dividend today, rose 2.1 per cent to $11.94. Among the other retirement village operators, Metlifecar­e gained 3.2 per cent to $6.22. Arvida, which goes ex-dividend for a 1.56 cent final

payment on June 12, rose 1.6 per cent to $1.30. Mainfreigh­t fell 1.2 per cent to $27.38. The transport company sheds its final dividend of 26 cents on July 12.

A2 Milk fell 0.9 per cent to $10.90, having been among the leading gainers on Tuesday. The milk marketer has fallen from a peak of $14.62 in late February on concern about increased rivalry in the Chinese market and on disappoint­ment margins haven’t grown as fast as sales.

Synlait Milk fell 2.2 per cent to $10.90.

Kathmandu declined 1.7 per cent

to $2.38. Fletcher Building rose 1.7 per cent to $6.69

NZX fell 0.9 per cent to $1.12 after the market operator’s monthly metrics showed share trading continued to rise in May. Year-to-date the total number of trades is up 79 per cent to 1.3 million and the total value traded is up 5.3 per cent to $17 billion, NZX said yesterday.

 ?? Photo / Dean Purcell ?? Fisher & Paykel Healthcare chief executive Lewis Gradon.
Photo / Dean Purcell Fisher & Paykel Healthcare chief executive Lewis Gradon.

Newspapers in English

Newspapers from New Zealand